| # | Title | Journal | Year | Citations |
|---|
| 1 | Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A review | Contemporary Clinical Trials Communications | 2018 | 540 |
| 2 | Different ways to estimate treatment effects in randomised controlled trials | Contemporary Clinical Trials Communications | 2018 | 289 |
| 3 | Master protocol trials in oncology: Review and new trial designs | Contemporary Clinical Trials Communications | 2018 | 81 |
| 4 | Teleconsent: A novel approach to obtain informed consent for research | Contemporary Clinical Trials Communications | 2016 | 75 |
| 5 | Choosing primary endpoints for clinical trials of health care interventions | Contemporary Clinical Trials Communications | 2019 | 69 |
| 6 | Factors affecting patient participation in clinical trials in Ireland: A narrative review | Contemporary Clinical Trials Communications | 2016 | 67 |
| 7 | Exercise training as S-Klotho protein stimulator in sedentary healthy adults: Rationale, design, and methodology | Contemporary Clinical Trials Communications | 2018 | 63 |
| 8 | Parents' perceived obstacles to pediatric clinical trial participation: Findings from the clinical trials transformation initiative | Contemporary Clinical Trials Communications | 2018 | 62 |
| 9 | Comparison of methods for the analysis of relatively simple mediation models | Contemporary Clinical Trials Communications | 2017 | 46 |
| 10 | The influence of race and ethnicity on becoming a human subject: Factors associated with participation in research | Contemporary Clinical Trials Communications | 2017 | 41 |
| 11 | Building clinical trials around patients: Evaluation and comparison of decentralized and conventional site models in patients with low back pain | Contemporary Clinical Trials Communications | 2018 | 41 |
| 12 | Suubi+Adherence study protocol: A family economic empowerment intervention addressing HIV treatment adherence for perinatally infected adolescents | Contemporary Clinical Trials Communications | 2019 | 40 |
| 13 | COVID-19 disparities: An urgent call for race reporting and representation in clinical research | Contemporary Clinical Trials Communications | 2020 | 40 |
| 14 | Successful collection of stool samples for microbiome analyses from a large community-based population of elderly men | Contemporary Clinical Trials Communications | 2017 | 38 |
| 15 | The significant cost of systematic reviews and meta-analyses: A call for greater involvement of machine learning to assess the promise of clinical trials | Contemporary Clinical Trials Communications | 2019 | 38 |
| 16 | A successful approach to minimizing attrition in racial/ethnic minority, low-income populations | Contemporary Clinical Trials Communications | 2017 | 37 |
| 17 | Mexican-American perspectives on participation in clinical trials: A qualitative study | Contemporary Clinical Trials Communications | 2016 | 35 |
| 18 | Patient preferences for using mobile technologies in clinical trials | Contemporary Clinical Trials Communications | 2019 | 35 |
| 19 | Comparison of study samples recruited with virtual versus traditional recruitment methods | Contemporary Clinical Trials Communications | 2020 | 33 |
| 20 | Lessons learned for recruitment and retention of low-income African Americans | Contemporary Clinical Trials Communications | 2020 | 33 |
| 21 | A pragmatic randomized trial comparing tablet computer informed consent to traditional paper-based methods for an osteoporosis study | Contemporary Clinical Trials Communications | 2016 | 32 |
| 22 | Estimation of treatment effects in weighted log-rank tests | Contemporary Clinical Trials Communications | 2017 | 32 |
| 23 | Biomarker-guided trials: Challenges in practice | Contemporary Clinical Trials Communications | 2019 | 32 |
| 24 | Intestinal-level anti-inflammatory bioactivities of catechin-rich green tea: Rationale, design, and methods of a double-blind, randomized, placebo-controlled crossover trial in metabolic syndrome and healthy adults | Contemporary Clinical Trials Communications | 2020 | 32 |
| 25 | Comparison of intent-to-treat analysis strategies for pre-post studies with loss to follow-up | Contemporary Clinical Trials Communications | 2018 | 31 |
| 26 | Barriers and facilitators to the participation of subjects in clinical trials: An overview of reviews | Contemporary Clinical Trials Communications | 2021 | 31 |
| 27 | A randomized efficacy trial of a cognitive-behavioral group intervention to prevent Internet Use Disorder onset in adolescents: The PROTECT study protocol | Contemporary Clinical Trials Communications | 2017 | 30 |
| 28 | Dementia Stigma Reduction (DESeRvE): Study protocol for a randomized controlled trial of an online intervention program to reduce dementia-related public stigma | Contemporary Clinical Trials Communications | 2019 | 30 |
| 29 | The efficacy and safety of setmelanotide in individuals with Bardet-Biedl syndrome or Alström syndrome: Phase 3 trial design | Contemporary Clinical Trials Communications | 2021 | 30 |
| 30 | Project BreakFAST: Rationale, design, and recruitment and enrollment methods of a randomized controlled trial to evaluate an intervention to improve school breakfast program participation in rural high schools | Contemporary Clinical Trials Communications | 2016 | 27 |
| 31 | Design of a randomized, controlled, comparative-effectiveness trial testing a Family Model of Diabetes Self-Management Education (DSME) vs. Standard DSME for Marshallese in the United States | Contemporary Clinical Trials Communications | 2017 | 27 |
| 32 | Metabolic and functional changes in transgender individuals following cross-sex hormone treatment: Design and methods of the GEnder Dysphoria Treatment in Sweden (GETS) study | Contemporary Clinical Trials Communications | 2018 | 27 |
| 33 | Main changes in European Clinical Trials Regulation (No 536/2014) | Contemporary Clinical Trials Communications | 2018 | 27 |
| 34 | Reporting of master protocols towards a standardized approach: A systematic review | Contemporary Clinical Trials Communications | 2019 | 27 |
| 35 | Intention-to-treat analysis when only a baseline value is available | Contemporary Clinical Trials Communications | 2020 | 27 |
| 36 | Patient participation in cancer clinical trials: A pilot test of lay navigation | Contemporary Clinical Trials Communications | 2016 | 26 |
| 37 | Clinical evaluation of Emblica Officinalis Gatertn (Amla) in healthy human subjects: Health benefits and safety results from a randomized, double-blind, crossover placebo-controlled study | Contemporary Clinical Trials Communications | 2020 | 26 |
| 38 | Random guess and wishful thinking are the best blinding scenarios | Contemporary Clinical Trials Communications | 2016 | 25 |
| 39 | Perceptions and attitudes to clinical research participation in Qatar | Contemporary Clinical Trials Communications | 2017 | 25 |
| 40 | Design of an anti-inflammatory diet (ITIS diet) for patients with rheumatoid arthritis | Contemporary Clinical Trials Communications | 2020 | 25 |
| 41 | Patients' knowledge and perceived understanding – Associations with consenting to participate in cancer clinical trials | Contemporary Clinical Trials Communications | 2016 | 24 |
| 42 | Cohort profile of the PRoteomic Evaluation and Discovery in an IBD Cohort of Tri-service Subjects (PREDICTS) study: Rationale, organization, design, and baseline characteristics | Contemporary Clinical Trials Communications | 2019 | 24 |
| 43 | Comparing different ways of calculating sample size for two independent means: A worked example | Contemporary Clinical Trials Communications | 2019 | 24 |
| 44 | Digital recruitment and enrollment in a remote nationwide trial of screening for undiagnosed atrial fibrillation: Lessons from the randomized, controlled mSToPS trial | Contemporary Clinical Trials Communications | 2019 | 24 |
| 45 | A dietary intervention to improve the microbiome composition of pregnant women with Crohn's disease and their offspring: The MELODY (Modulating Early Life Microbiome through Dietary Intervention in Pregnancy) trial design | Contemporary Clinical Trials Communications | 2020 | 24 |
| 46 | Establishment of an International Collaborative Network for N-of-1 Trials and Single-Case Designs | Contemporary Clinical Trials Communications | 2021 | 24 |
| 47 | The administration of patient-reported outcome questionnaires in cancer trials: Interviews with trial coordinators regarding their roles, experiences, challenges and training | Contemporary Clinical Trials Communications | 2018 | 23 |
| 48 | Prognostic significance of lymph node yield and lymph node ratio in patients affected by squamous cell carcinoma of the oral cavity and oropharynx: Study protocol for a prospective, multicenter, observational study | Contemporary Clinical Trials Communications | 2019 | 23 |
| 49 | Operational strategies in US cancer centers of excellence that support the successful accrual of racial and ethnic minorities in clinical trials | Contemporary Clinical Trials Communications | 2020 | 23 |
| 50 | Patient perceptions concerning clinical trials in oncology patients | Contemporary Clinical Trials Communications | 2016 | 22 |
